ZNF969P

Across TCGA pan-cancer cohorts, ZNF969P RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of ZNF969P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF969P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF969P is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRC, HNSC, and LUSC are the cancer types where ZNF969P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF969P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.041	<.001	7	view →
HNSC	Male	III,IV	+0.021	<.001	7	view →
LUSC	All	All	+0.045	.005	4	view →
BLCA	Female	IV	+0.036	.005	4	view →
STAD	All	All	+0.097	.018	2	view →
THCA	Male	III,IV	+0.032	.005	2	view →
KICH	All	II,III,IV	−0.021	.030	2	view →
LUAD	All	All	+0.017	.015	2	view →
COAD	All	All	+0.017	.032	2	view →
BRCA	All	All	+0.014	.019	2	view →
CHOL	All	All	+0.032	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

ZNF969P–KIRC

Open the KIRC breakdown →